Skip to main navigation Skip to search Skip to main content

Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis

  • Kiki Janssen
  • , Stefan Buttner
  • , M Suker
  • , Berend Beumer
  • , P Addeo
  • , P Bachellier
  • , N Bahary
  • , T Bekaii-Saab
  • , MA Bali
  • , MGH Besselink
  • , BA Boone
  • , I Chau
  • , S Clarke
  • , M Dillhoff
  • , BF El-Rayes
  • , JM Frakes
  • , D Grose
  • , PJ Hosein
  • , NB Jamieson
  • , AA Javed
  • K Khan, KP Kim, SC Kim, SS Kim, AH Ko, J Lacy, GA Margonis, MD McCarter, CJ McKay, EA Mellon, SY Moorcraft, KI Okada, A Paniccia, PJ Parikh, NA Peters, H Rabl, J Samra, C Tinchon, G van Tienhoven, E van Veldhuisen, A Wang-Gillam, MJ Weiss, JW Wilmink, H Yamaue, Marjolein Homs, Casper van Eijck, MHG Katz, B Groot Koerkamp

Research output: Contribution to journal › Article › Academic › peer-review

298 Citations (Scopus)
Original languageUndefined/Unknown
Article numberdjz073
Pages (from-to)782-794
Number of pages13
JournalJournal of the National Cancer Institute
Volume111
Issue number8
DOIs
Publication statusPublished - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research programs

  • EMC COEUR-09
  • EMC MM-03-86-08
  • EMC MM-04-47-07

Cite this